Cristin L. Rothfuss

Cristin L. Rothfuss

Executive Vice President, General CounselatSarepta Therapeutics· In proxies 2023–2025

Pay in FY2025Sarepta Therapeutics stock -82.3% the same year

Cristin L. Rothfuss was paid $4.2M in FY2025 (Dec). Sarepta Therapeutics stock fell 82.3% that year.

Pay$100 in the stock at the end of FY22 → $17
Pay is from the Summary Compensation Table of each Sarepta Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Sarepta TherapeuticsPublic company · 3 yr
    • Executive Vice President, General Counsel2023 – Present · 3 yrStock in role -85%
  2. Boston DayPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?